Forcados C, Köksal H, Scherer E, Abrantes R, Dillard P, Duarte HO, Josefsson S, Gomes C, de Montlaur C, Hellesøy HTZ, Dunkel R, Smeland EB, Myklebust JH, Reis CA, McCormack E, Gelebart P, Inderberg EM, Wälchli S (2026)
Reviving low-affinity glycan-targeting CAR with combinatorial design
Cell Rep Med, 103108 (in press)
DOI 10.1016/j.xcrm.2026.103108, PubMed 42849448

Villatoro A, Dougé A, Krpina K, Schmitz LM, Forcados C, Kaveh F, Arias-Díaz AE, Gelebart P, McCormack E, Stripecke R, Abal M, Davidson B, Inderberg EM, Wälchli S (2026)
Combining TAG-72CAR with anti-MUC16CAR improves the potency of ovarian cancer treatment
FEBS J (in press)
DOI 10.1111/febs.70760, PubMed 42834815

Dillard P, Köksal H, Maggadottir SM, Winge-Main A, Pollmann S, Menard M, Myhre MR, Mælandsmo GM, Flørenes VA, Gaudernack G, Kvalheim G, Wälchli S, Inderberg EM (2026)
Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy
Mol Ther (in press)
DOI 10.1016/j.ymthe.2026.09.027, PubMed 42800469